Evidence map›Paper›PMID 32043226›Full record

ArticlePlant molecular biology2020

Auxin treatment of grapevine (Vitis vinifera L.) berries delays ripening onset by inhibiting cell expansion.

Silvia Dal Santo, Matthew R Tucker, Hwei-Ting Tan, Crista A Burbidge, Marianna Fasoli, Christine Böttcher, Paul K Boss, Mario Pezzotti, Christopher Davies

Abstract read
PubMed Publisher
In one paragraph

Article in Plant molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Auxin as an architect of the pectin matrix.Journal of experimental botany · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Silvia Dal SantoDepartment of Biotechnology, University of Verona, Strada Le Grazie 15, 37134, Verona, Italy.
Matthew R TuckerSchool of Agriculture, Food and Wine, Level 4, Main WIC Building, University of Adelaide, Waite Campus, Urrbrae, SA, 5064, Australia.
Hwei-Ting TanSchool of Agriculture, Food and Wine, Level 4, Main WIC Building, University of Adelaide, Waite Campus, Urrbrae, SA, 5064, Australia.
Crista A BurbidgeCSIRO Agriculture and Food, Locked Bag 2, Glen Osmond, SA, 5064, Australia.
Marianna FasoliE. & J. Gallo Winery, 600 Yosemite Blvd, Modesto, CA, 95354, USA.
Christine BöttcherCSIRO Agriculture and Food, Locked Bag 2, Glen Osmond, SA, 5064, Australia.
Paul K BossCSIRO Agriculture and Food, Locked Bag 2, Glen Osmond, SA, 5064, Australia.
Mario PezzottiDepartment of Biotechnology, University of Verona, Strada Le Grazie 15, 37134, Verona, Italy.
Christopher DaviesCSIRO Agriculture and Food, Locked Bag 2, Glen Osmond, SA, 5064, Australia. christopher.davies@csiro.au.ORCID http://orcid.org/0000-0002-4942-9540
Commonwealth Scientific and Industrial Research Organisation · AUThe University of Adelaide · AUUniversity of Verona · ITErnest Gallo Clinic and Research Center · US

Funding

ARC Centre of Excellence in Plant Cell walls CE1101007Commonwealth Scientific and Industrial Research Organisation OD-205844European Cooperation in Science and Technology FA17111Regione del Veneto 1695-11-11-2018Wine Australia CSA 1701-2.2
6 · The paper itself

Abstract

key messageAuxin treatment of grape (Vitis vinifera L.) berries delays ripening by inducing changes in gene expression and cell wall metabolism and could combat some deleterious climate change effects. Auxins are inhibitors of grape berry ripening and their application may be useful to delay harvest to counter effects of climate change. However, little is known about how this delay occurs. The expression of 1892 genes was significantly changed compared to the control during a 48 h time-course where the auxin 1-naphthaleneacetic acid (NAA) was applied to pre-veraison grape berries. Principal component analysis showed that the control and auxin-treated samples were most different at 3 h post-treatment when approximately three times more genes were induced than repressed by NAA. There was considerable cross-talk between hormone pathways, particularly between those of auxin and ethylene. Decreased expression of genes encoding putative cell wall catabolic enzymes (including those involved with pectin) and increased expression of putative cellulose synthases indicated that auxins may preserve cell wall structure. This was confirmed by immunochemical labelling of berry sections using antibodies that detect homogalacturonan (LM19) and methyl-esterified homogalacturonan (LM20) and by labelling with the CMB3a cellulose-binding module. Comparison of the auxin-induced changes in gene expression with the pattern of these genes during berry ripening showed that the effect on transcription is a mix of changes that may specifically alter the progress of berry development in a targeted manner and others that could be considered as non-specific changes. Several lines of evidence suggest that cell wall changes and associated berry softening are the first steps in ripening and that delaying cell expansion can delay ripening providing a possible mechanism for the observed auxin effects.

Indexed as

Cell EnlargementCell WallFruitGene Expression Regulation, PlantIndoleacetic AcidsNaphthaleneacetic AcidsPlant CellsPlant Growth RegulatorsTimeVitis1-naphthaleneacetic acidIndoleacetic AcidsNaphthaleneacetic AcidsPlant Growth RegulatorsAuxinCell wallsGene expressionGrape ripeningRipeningTranscriptome

Identifiers

PMID32043226
OpenAlexW3005567443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.